Skip to main content

Part of UT Health San Antonio

Profiles - UT Health San AntonioProfiles - UT Health Science Center San Antonio

Part of UT Health San Antonio

Menu
  • Home

You are here

  • Profiles Home
  • Faculty Directory
  • Bai, Juli, Ph.D.
Juli Bai, Ph.D.

Contact

210-567-4526

baij@uthscsa.edu

Programs

  • Ph.D. in Integrated Biomedical Sciences

Departments & Divisions

  • Department of Pharmacology

Juli Bai, Ph.D.

Assistant Professor/Research

Obesity, which is characterized by increased adiposity, has reached epidemic proportions globally. The major focus of my research effort concerns the mechanisms underlying obesity-induced insulin resistance, sterile chronic inflammation, and energy imbalance. Particularly, I’m interested in the crosstalk between innate immune cGAS signaling and metabolic dysfunction. We used different tissue-specific transgenic and/or knockout mouse models as well as cell culture studies to elucidate the key signaling mechanism in the regulation of the metabolic diseases. Better understanding of these key mechanisms will provide important information for the development of novel therapeutic targets for the treatment of obesity and its related diseases.

  • Professional Background

    Education

    • 2006 - PhD - Environmental Medicine - Shanxi University
    • 2003 - MS - Environmental Medicine - Shanxi University
    • 2000 - BS - Biochemistry - Shanxi University
    • Postdoctoral Training - Obesity and Diabetes - The University of Texas Health Science Center at San Antonio

    Training

    • 2011 - Postdoctoral fellowship - UT Health San Antonio

    Appointments

    • 2/2018 - Instructor/Research - UT Health San Antonio, Pharmacology, San Antonio
    • 2/2019 - Assistant Professor/Research - UT Health San Antonio, Pharmacology, San Antonio
  • Research & Grants

    Innovative Basic Science Award of American Diabetes Association

    1-19-IBS-147  (PI: Juli Bai)  01/2019-12-2021

    Title: The role of the cGAS-cGAMP pathway in regulating energy homeostasis.

    The major goal of this study is to determine the role of cGAS-cGAMP pathway in the regulation of energy homeostasis, insulin sensitivity in adipose tissue.

  • Publications

    • Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutrition-induced obesity
    • Potential Roles of Adiponectin Isoforms in Human Obesity with Delayed Wound Healing
    • Rheb promotes brown fat thermogenesis by Notch-dependent activation of the PKA signaling pathway
    • The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism
    • DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING
    • Rheb Inhibits Beiging of White Adipose Tissue via PDE4D5-Dependent Downregulation of the cAMP-PKA Signaling Pathway
    • Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance
    • Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1
map image

UT Health San Antonio

7703 Floyd Curl Drive
San Antonio, TX 78229

210-567-7000

We make lives better ©

We're a part of UT Health San Antonio, provider of comprehensive health,  dental, &  cancer care,  advanced academics,  and  life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.